CaamTech

https://caam.tech/foundational-science-for-the-psilocybin-analog-4-pro-dmt-in-mice/

Foundational Science for the Psilocybin Analog 4-PrO-DMT | CaaMTech 4-Pro-DMT is a synthetic psilocybin analog and purported prodrug of psilocin

CaaMTech Synthesizes and Characterizes Monoalkyl Tryptamine 4-HO-NiPT

4-HO-NiPT is an active metabolite of 4-HO-DiPT and closely related to norpsilocin

CaaMTech Synthesizes and Characterizes Monoalkyl Tryptamine 4-HO-NiPT 4-HO-NiPT is an active metabolite of 4-HO-DiPT and closely related to norpsilocin

https://caam.tech/caamtech-collaboration-proves-diversity-in-magic-mushroom-chemistry/

CaaMTech Collaboration Proves Diversity in Magic Mushroom Chemistry A new paper published by The Leibniz Institute for Natural Product Research in collaboration with CaaMTech reveals the complex chemistry of magic mushrooms

Caamtech CEO, Andrew Chadeayne, recently appeared on the Mind & Matter Podcast with Nick Jikomes. In this informative episode, Andrew and Nick discuss the of , the industry and much more! Listen to the full episode here: https://mindandmatter.substack.com/p/andrew-chadeayne-chemistry-of-magic-dc0

CaaMTech collaborates with University of Massachusetts Dartmouth to solve crystal structure of overlooked baeocystin

While continues to receive attention as the active ingredient in magic , CaaMTech scientists have continued filling the unmet need for fundamental scientific understanding of the “other” alkaloids.

https://caam.tech/minor-magic-mushroom-compound-crystal-structure-solved/

“Minor” Magic Mushroom Compound Crystal Structure Solved | CaaMTech CaaMTech collaborates with UMass Dartmouth to solve crystal structure of overlooked baeocystin

CaamTech scientists have solved the crystal structure of freebase serotonin for the first time

https://caam.tech/caamtech-solves-serotonin-crystal-structure/

CaaMTech Solves Serotonin Crystal Structure | CaaMTech CaaMTech scientists have solved the crystal structure of freebase serotonin for the first time

We're excited to welcome Dr. Robert (Bob) Discordia to the CaamTech team as Chief Scientific Officer! Bob brings over 30 years of industry experience to CaaMTech.

Bob Discordia Joins CaaMTech as Chief Scientific Officer Dr. Discordia brings over 30 years of pharmaceutical industry experience to CaaMTech

Do you have a PhD in Neuroscience, Psychology, Biomedical Sciences, or a related field? Are you interested in cutting edge research at the nexus of and treatment? The University of Wyoming is offering a unique opportunity to research CaamTech’s unparalleled library of tryptamines as a Post Doctoral Research Associate. Join Dr. Ana Clara Bobadilla’s team in researching CaaMTech’s next-generation psychedelic drugs in addiction models by visiting the link below:

Post Doc Res Assoc The Bobadilla Lab at the University of Wyoming has a fully-funded, immediate opening for a motivated and enthusiastic postdoctoral research associate. Our team investigates the neurobiological mechanisms of relapse to drugs. Specifically, we characterize the ensembles of neurons that drive reward-se...

CaaMTech Raises $22 Million for Drug Discovery and Development

The investment provides CaaMTech with capital to advance compounds from its library into clinical trials

CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development The investment provides CaaMTech with capital to advance compounds from its library into clinical trials